BEGIN:VCALENDAR
VERSION:2.0
PRODID:IEEE vTools.Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
DTSTART:20240310T030000
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:MDT
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20241103T010000
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:MST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20240906T184723Z
UID:6B12EF69-6B65-4F2E-9E19-8277F9D2C837
DTSTART;TZID=America/Denver:20240905T190000
DTEND;TZID=America/Denver:20240905T200000
DESCRIPTION:This is an EMBS Distinguished Lecture by Dr. Shankar Subramania
 m of University of California San Diego. Dr. Subramaniam is a Distinguishe
 d Professor of Bioengineering\, Computer Science and Engineering\, Cellula
 r and Molecular Medicine\, and Nano Engineering. The lecture will include 
 metrics of cognition such as dementia provide the first clues to neurodege
 nerative disorders like Alzheimer’s disease. What are the early events t
 hat presage the onset of dementia? How is the brain reprogrammed in Alzhei
 mer’s disease? Is there a hope of reversing Alzheimer’s disease? Do ot
 her neurodegenerative diseases like Parkinson’s and Huntington’s show 
 similar reprogramming? Do mechanisms of reprogramming offer a strategy for
  drug screening? Can we develop human brain models for AD? This talk will 
 address these issues from molecular and cellular perspectives.\n\nSpeaker(
 s): Dr. Shankar Subramaniam\, \n\nVirtual: https://events.vtools.ieee.org/
 m/431942
LOCATION:Virtual: https://events.vtools.ieee.org/m/431942
ORGANIZER:lwhitby@ieee.org
SEQUENCE:33
SUMMARY:A Distinguished Lecture on\, "How is the Human Brain Reprogrammed i
 n Alzheimer's Disease?"
URL;VALUE=URI:https://events.vtools.ieee.org/m/431942
X-ALT-DESC:Description: <br /><p>This is an EMBS Distinguished Lecture by D
 r. Shankar Subramaniam of University of California San Diego.&nbsp\; Dr. S
 ubramaniam is a Distinguished Professor of Bioengineering\, Computer Scien
 ce and Engineering\, Cellular and Molecular Medicine\, and Nano Engineerin
 g.&nbsp\; The lecture will include m<span style="color: rgb(0\, 0\, 0)\;">
 <span style="font-size: 12pt\; line-height: 107%\; font-family: Calibri\, 
 sans-serif\;">etrics of cognition such as dementia provide the first clues
  to neurodegenerative disorders like Alzheimer&rsquo\;s disease. What are 
 the early events that presage the onset of dementia? How is the brain repr
 ogrammed in Alzheimer&rsquo\;s disease? Is there a hope of reversing Alzhe
 imer&rsquo\;s disease? Do other neurodegenerative diseases like Parkinson&
 rsquo\;s and Huntington&rsquo\;s show similar reprogramming? Do mechanisms
  of reprogramming offer a strategy for drug screening? Can we develop</spa
 n><span style="font-size: 12pt\; line-height: 107%\; font-family: Calibri\
 , sans-serif\;"> human </span><span style="font-size: 12pt\; line-height: 
 107%\; font-family: Calibri\, sans-serif\;">brain models for AD? This talk
  will address these issues from molecular and cellular perspectives.</span
 ></span></p>
END:VEVENT
END:VCALENDAR